Total Payments
$30,100
2024 Payments
$3,063
Companies
55
Transactions
1,329
Medicare Patients
6,506
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$21,868 (72.7%)
Consulting$6,925 (23.0%)
Other$850.00 (2.8%)
Education$337.39 (1.1%)
Travel$119.90 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,868 | 1,316 | 72.7% |
| Consulting Fee | $6,925 | 3 | 23.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $850.00 | 1 | 2.8% |
| Education | $337.39 | 8 | 1.1% |
| Travel and Lodging | $119.90 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $6,239 | 139 | $0 (2024) |
| ABBVIE INC. | $4,317 | 263 | $0 (2024) |
| Lilly USA, LLC | $3,862 | 69 | $0 (2024) |
| Amgen Inc. | $2,910 | 166 | $0 (2024) |
| Janssen Biotech, Inc. | $2,865 | 120 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,284 | 73 | $0 (2024) |
| PFIZER INC. | $1,260 | 82 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,058 | 56 | $0 (2024) |
| Celgene Corporation | $619.56 | 38 | $0 (2019) |
| Genentech USA, Inc. | $614.15 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,063 | 152 | ABBVIE INC. ($1,044) |
| 2023 | $2,413 | 114 | AbbVie Inc. ($630.48) |
| 2022 | $2,917 | 129 | ABBVIE INC. ($702.28) |
| 2021 | $2,431 | 156 | Amgen Inc. ($437.28) |
| 2020 | $2,095 | 119 | Amgen Inc. ($565.61) |
| 2019 | $7,160 | 228 | Lilly USA, LLC ($3,066) |
| 2018 | $5,827 | 185 | UCB, Inc. ($3,339) |
| 2017 | $4,196 | 246 | UCB, Inc. ($1,131) |
All Payment Transactions
1,329 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,263 | 100,045 | $3.7M | $923,703 |
| 2022 | 17 | 1,378 | 83,143 | $3.3M | $923,308 |
| 2021 | 27 | 1,867 | 80,988 | $2.8M | $1.1M |
| 2020 | 29 | 1,998 | 31,617 | $1.4M | $724,964 |
Total Patients
6,506
Total Services
295,793
Medicare Billing
$3.7M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 18 | 9,700 | $1.2M | $289,401 | 23.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 28 | 21,098 | $774,632 | $219,462 | 28.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 62,400 | $1.1M | $209,734 | 19.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 40 | 3,780 | $154,980 | $69,644 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 748 | $184,008 | $60,379 | 32.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 56 | 321 | $123,395 | $28,981 | 23.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 57 | 373 | $74,600 | $16,926 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 88 | $30,272 | $10,113 | 33.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 178 | 451 | $18,040 | $4,239 | 23.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 185 | 485 | $10,670 | $4,032 | 37.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 17 | 31 | $11,780 | $2,317 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,742 | $2,177 | 37.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 179 | 396 | $5,940 | $2,127 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 37 | $6,401 | $2,043 | 31.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 41 | $7,260 | $2,038 | 28.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 33 | 78 | $1,170 | $89.45 | 7.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 14 | 8,375 | $1.1M | $280,805 | 26.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 26 | 23,100 | $854,700 | $268,607 | 31.4% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 17 | 44,400 | $754,800 | $179,540 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 376 | 869 | $213,774 | $70,272 | 32.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 41 | 4,020 | $164,820 | $66,473 | 40.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 43 | 151 | $58,135 | $14,730 | 25.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 40 | 171 | $33,345 | $8,184 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 214 | 637 | $25,480 | $6,135 | 24.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 42 | 120 | $24,000 | $5,771 | 24.0% |
About Dr. Christopher Colglazier, MD
Dr. Christopher Colglazier, MD is a Rheumatology healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679555486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Colglazier, MD has received a total of $30,100 in payments from pharmaceutical and medical device companies, with $3,063 received in 2024. These payments were reported across 1,329 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($21,868).
As a Medicare-enrolled provider, Colglazier has provided services to 6,506 Medicare beneficiaries, totaling 295,793 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Crestview Hills, KY
- Active Since 11/17/2005
- Last Updated 10/08/2013
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1679555486
Products in Payments
- TALTZ (Drug) $3,733
- Cimzia (Drug) $3,115
- SIMPONI ARIA (Biological) $2,088
- RINVOQ (Biological) $1,540
- Enbrel (Biological) $1,540
- XELJANZ (Drug) $1,088
- ORENCIA (Biological) $960.26
- Humira (Biological) $861.66
- COSENTYX (Biological) $834.19
- Otezla (Drug) $828.89
- TREMFYA (Drug) $717.79
- HUMIRA (Biological) $708.35
- SKYRIZI (Biological) $578.61
- SAPHNELO (Biological) $539.62
- BENLYSTA (Biological) $499.11
- EVENITY (Biological) $485.24
- STELARA (Biological) $468.72
- KRYSTEXXA (Biological) $442.38
- Rituxan (Biological) $351.51
- COSENTYX (Drug) $326.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Crestview Hills
Dr. Rebecca Callis, M.d, M.D
Rheumatology — Payments: $326,993
Rheumatology $326,993
Liza Varghese, Md, MD
Rheumatology — Payments: $24,459
Rheumatology $24,459
Kerrin Burte, Md, MD
Rheumatology — Payments: $19,098
Rheumatology $19,098
Mazen Elyan, Md, MD
Rheumatology — Payments: $7,360
Rheumatology $7,360
Dr. Magdalena Winiarska, Md, MD
Rheumatology — Payments: $5,480
Rheumatology $5,480
Arthur Kunath, Md, MD
Rheumatology — Payments: $4,085
Rheumatology $4,085